Ekaterina V. Tarasenko

Ekaterina V. Tarasenko

Auto-generated profile, based on publicly available information

Ekaterina V. Tarasenko

Department of Biology and General Genetics, Peoples’ Friendship University of Russia, Moscow, Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2019 in Russian Open Medical Journal
Verified
Journal Article
Open access
GMGalina I. Myandina
Galina I. Myandina
HAHasan Mohammad Hasan Alhejoj
Hasan Mohammad Hasan Alhejoj
MAMadina Azova
Madina Azova
ETEkaterina V. Tarasenko
Ekaterina V. Tarasenko
NKNina Kulchenko
Nina Kulchenko
Background ― Genetic polymorphisms analysis of metabolic and antioxidant systems pathway genes are associated with male infertility is the most perspective and developed field in andrology. Purpose ― the aim of the research is to reveal the association of the glutathione S-transferase gene GSTP1 polymorphism C/T (rs1138272) with risk of pathospermia in Russian men in Moscow region. Material and Methods ― Case control study was conducted on 68 fertile men and 70 infertile men with various forms of pathospermia. Sperm analysis was performed according to WHO guidelines (WHO, 2010). DNA was extracted from peripheral blood leukocytes. Genotyping of the GSTP1 gene polymorphisms was carried out by generated amplicons from melting curve analysis after real time PCR. Results ― statistically significant association of polymorphism GSTP1 C/T (Ala/Val; rs1138272) with asthenozoospermia (χ2=8.58, p=0.003) and teratospermia (χ2=6.81, p=0.009) risk was found. The frequencies of homozygous and heterozygous carries (CT+TT genotypes) for polymorphic locus GSTP1 gene (rs1138272) are 3 times higher for men with disturbance of motility of spermatozoa and 2.5 times higher for men with abnormalities in morphology of spermatozoa, then for men with normozoospermia. Conclusion ― The GSTP1 C>T polymorphism (rs1138272) associated with risk of teratospermia and asthenozoospermia in male of reproductive age.

15 February 2021 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
MKM.G. Kantemirova
M.G. Kantemirova
MHMoscow Morozov Children’s City Clinical Hospital
Moscow Morozov Children’s City Clinical Hospital
SKS.KH. Kurbanova
S.KH. Kurbanova
YNYu.YU. Novikova
Yu.YU. Novikova
MAMadina Azova
Madina Azova
DOD.YU. Ovsyannikov
D.YU. Ovsyannikov
Kawasaki disease (KD) is a multifactorial disease with a genetic predisposition, systemic vasculitis complicated by the formation of coronary artery aneurysms (CAA). Its pathogenesis is based on immune inflammation with an increase in the concentration of pro-inflammatory cytokines, the level of C-reactive protein (CRP), and coagulation disorder. Objective of the study: to search for polymorphisms of genes interleukin-6 (IL6), vascular endothelial growth factor A (VEGFA), cluster of differentiation CD14, CRP, fibrinogen beta chain (FGB), associated with the KD development and a predisposition to the CAA formation among patients with KD living in Moscow and the Moscow region. Materials and methods: genotyping for gene polymorphisms IL6 –174G>C (rs1800795), VEGFA –634 C>G (rs2010963), CD14 –159 C>T (rs2569190), CRP 3872 C>T (rs1205), FGB – 455 G>A (rs1800790) by PCR in 31 children 1 month – 10 years old (median age 19 months [9,0; 38,5]) with KD, among them, in 10 patients the disease was complicated by CAA formation according to echocardiography, and 30 children of the control group. Results: statistically significant differences (pT, CRP 3872 C>T and FGB –455 G>A genes among patients with KD and children of the control group; when comparing the results of KD patients with CAA and the control group, statistically significant differences (pT. Conclusion: it can be assumed that these polymorphisms are associated with the development of KD and CAA in these patients.

22 June 2026 in Bulletin of the Medical Institute of Continuing Education
Verified
Journal Article
Open access
GMGalina Myandina
Galina Myandina
SKSergey Kurevlev
Sergey Kurevlev
ETEkaterina Tarasenko
Ekaterina Tarasenko
AKAndrey Kuchuk
Andrey Kuchuk
Background. The pandemic of coronavirus disease COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a major obstacle for the performing of current medical activities throughout the world in XXI. Infection with SARS-CoV-2 has systemic damages to lungs, heart, and kidney, nervous and reproductive systems. Many published studies to date have pointed out that COVID-19 could also affect fertility and disrupt the functions of the reproductive system. Main content. This literature review presents current scientific data on the short-term and potential long-term consequences of COVID-19 on male fertility, including an analysis of the reversibility of impairments and the risk of infertility. The possible impairment of the male reproductive system is because angiotensin-converting enzyme 2 (ACE2) receptors are in an increased number in the testes, seminiferous duct cells, spermatogonia, Leydig cells and Sertoli cells. COVID-19 infection affects sperm quality, DNA fragmentation index (DFI) and hormonal status. Conclusion. The numerous scientific data confirm the impairment of spermatogenesis during the Covid-19 infection. The timing and extent of reproductive function recovery after infection in the long-term period remain unknown. The uncertainty of long-term consequences, amid a global trend of declining spermatogenesis, underscores the high clinical and social significance of this problem.

17 December 2018 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
АИАлександр Сергеевич Иванов
Александр Сергеевич Иванов
IGIrina V. Garmasch
Irina V. Garmasch
ОАОльга Сергеевна Аришева
Ольга Сергеевна Аришева
МММария Анатольевна Маркова
Мария Анатольевна Маркова
АМАнна Сергеевна Мельник
Анна Сергеевна Мельник
ВБВалерия Юрьевна Баронец
Валерия Юрьевна Баронец
Background: Uncontrolled use of alcohol can lead to the development of cirrhosis of the liver, which is manifested by fibrosis with the formation of regenerative nodes, an increase in pressure in the portal vein system and impaired liver function. Hepatic endothelium dysfunction during the formation of portal hypertension is accompanied by an increase in the level of protein molecules involved in the functioning of the endothelium: vascular endothelial growth factor A (VEGF-A), a soluble form of the intercellular adhesion molecule (s-ICAM-1) and endothelin-1 (ET -one). It is assumed that elevated levels of VEGF-A, s-ICAM-1 and ET-1 in alcoholic liver cirrhosis (AHC) may be interconnected with the structure of polymorphic loci, the promoter regions of the respective genes, which in turn may be a genetic risk factor for developing cirrhosis.Aims: Investigate the relationship of carriage of variant forms of polymorphic loci located in the promoter regions of VEGF-A, ICAM-1 and ET-1 with the level of the corresponding proteins in the blood serum and the risk of AHC.Materials and methods: The main group consisted of patients with pathological dependence on alcohol, aggravated by cirrhosis of the liver (AHC, n=60). The control group consisted of persons suffering from alcohol abuse, without liver pathology (AA, n=24). The observation period was the period of hospitalization. The serum levels of VEGF-A, s-ICAM-1 and ET-1 were evaluated by enzyme immunoassay. The distribution of variant forms of polymorphic loci located in the promoter regions of the VEGF-A genes (rs699947 and rs2010963), ICAM1 (rs281437) and ET-1 (rs1800541) in the studied sample was performed by real-time PCR.Results: The development of alcoholic cirrhosis was accompanied by a significant increase in the concentration of VEGF-A, s-ICAM-1 and ET-1 in serum. At the same time, direct correlations between the concentrations of VEGF-A, s-ICAM-1 and ET-1 in serum and the diameter of the portal vein in persons with liver cirrhosis were revealed. Patients with AHC are often carriers of the G allele of rs1800541 locus, located in the promoter of the ET-1 gene, compared with individuals suffering from control without liver pathology, which is associated with an increased risk of developing cirrhosis in alcohol dependence. The carriage of the C allele rs699947, as well as the C allele rs2010963 located in the promoter of the VEGF gene was associated with an increased level of VEGF-A in the AHC compared to carriers of this allele in the AA group. In addition, in the group of patients with AHC, carriers of allele C, homozygous CC genotype and heterozygous GC genotype of rs2010963 locus compared with carriers of G allele or homozygous GG genotype, respectively, were characterized by elevated serum VEGF-A levels.Conclusion: Carrier allele G of the rs1800541 locus (ET-1) is a risk factor for liver cirrhosis with alcohol abuse. The carriage of the C allele rs699947, as well as the C allele rs2010963 located in the promoter of the VEGF gene, can determine the elevated serum VEGF-A level in the AHC.